Lueno pharmaceutical package: repurchased 2.3258 million shares, total amount of funds used 39.2522 million yuan.

Lino Medicine Announcement: As of May 13, 2025, the company has repurchased a total of 2.3258 million shares of the company through a special securities account for repurchase, representing 1.00% of the total share capital of the company, through centralized competitive trading. The highest transaction price for the repurchased shares was 17.97 yuan per share, the lowest transaction price was 15.66 yuan per share, and the total transaction amount was 39.2522 million yuan. This repurchase complies with relevant laws and regulations and the company's repurchase program requirements.